Modern Chinese Medicine Announces Year 2021 Annual Results
Solid growth driven by extensive distribution network and strong R&D PERFORMANCE HIGHLIGHTS * The Group posted a consolidated revenue of approximately RMB360.7 million for the year ended31 December 2021, representing an increase of approximately 16.8% * For the year ended 31 December 2021, t...
Modern Chinese Medicine Announces Year 2021 Interim Results
PERFORMANCE HIGHLIGHTS * Revenue increased by 8.8% to RMB171.8 million * Gross profit increased by 10.4% to RMB78.6 million * Profit after tax increased by 10.5% to approximately RMB44.1 million * The increase in revenue was primarily driven by the surge in revenue generated from the sales...
Modern Chinese Medicine Announces Year 2020 Annual Results
Solid growth with focus to broaden the distribution network and raise R&D efforts PERFORMANCE HIGHLIGHTS * The Group posted a consolidated revenue of approximately RMB308.7 million for the year ended31 December 2020, representing an increase of approximately 41.1%. * For the year ended 31 D...
Modern Chinese Medicine Group Co., Ltd. Trading Debut Closed at HK$1.26 Per Share
HONG KONG, Jan. 15, 2021 /PRNewswire/ -- Modern Chinese Medicine Group Co., Ltd. ("Modern Chinese Medicine", together with its subsidiaries, the "Group"; stock code: 1643), which principally engages in the production of proprietary Chinese medicine (the "PCM") and offers both over-the-counter (the...
Modern Chinese Medicine Group Co., Ltd. announces its subscription results
HONG KONG, Jan. 14, 2021 /PRNewswire/ -- Modern Chinese Medicine Group Co., Ltd. ("Modern Chinese Medicine", together with its subsidiaries, the "Group"; stock code: 1643), which principally engages in the production of proprietary Chinese medicine (the "PCM") and offers both over-the-counter (the...
Modern Chinese Medicine Group Co., Ltd. to raise a maximum of approximately HK$221 million by way of Public Offer and Placing
Highlights * The Group principally engages in the production of proprietary Chinese medicine (the "PCM") in particular, and the Group offers both OTC and prescribed medicines intended for use by the Middle-aged and the Elderly in the PRC. * During the Track Record Period and up to 21 Decembe...